[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

COVID-19 Impact on Global Antimicrobial Therapeutics Market Size, Status and Forecast 2020-2026

August 2020 | 98 pages | ID: C1135F4B41E4EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report focuses on the global Antimicrobial Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Antimicrobial Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Merck & Co Inc.
  • Pfizer Inc.
  • Sanofi
  • ...
Market segment by Type, the product can be split into
  • Hospital
  • Clinic
  • Personal
  • Other
Market segment by Application, split into
  • Antiviral
  • Antibacterial
  • Antifungal
  • Antiparasitic
Market segment by Regions/Countries, this report covers
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America
The study objectives of this report are:
  • To analyze global Antimicrobial Therapeutics status, future forecast, growth opportunity, key market and key players.
  • To present the Antimicrobial Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Antimicrobial Therapeutics are as follows:
  • History Year: 2015-2019
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Antimicrobial Therapeutics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Antimicrobial Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Hospital
  1.4.3 Clinic
  1.4.4 Personal
  1.4.5 Other
1.5 Market by Application
  1.5.1 Global Antimicrobial Therapeutics Market Share by Application: 2020 VS 2026
  1.5.2 Antiviral
  1.5.3 Antibacterial
  1.5.4 Antifungal
  1.5.5 Antiparasitic
1.6 Coronavirus Disease 2019 (Covid-19): Antimicrobial Therapeutics Industry Impact
  1.6.1 How the Covid-19 is Affecting the Antimicrobial Therapeutics Industry
    1.6.1.1 Antimicrobial Therapeutics Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Antimicrobial Therapeutics Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Antimicrobial Therapeutics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Antimicrobial Therapeutics Market Perspective (2015-2026)
2.2 Antimicrobial Therapeutics Growth Trends by Regions
  2.2.1 Antimicrobial Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Antimicrobial Therapeutics Historic Market Share by Regions (2015-2020)
  2.2.3 Antimicrobial Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Antimicrobial Therapeutics Market Growth Strategy
  2.3.6 Primary Interviews with Key Antimicrobial Therapeutics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Antimicrobial Therapeutics Players by Market Size
  3.1.1 Global Top Antimicrobial Therapeutics Players by Revenue (2015-2020)
  3.1.2 Global Antimicrobial Therapeutics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Antimicrobial Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Antimicrobial Therapeutics Market Concentration Ratio
  3.2.1 Global Antimicrobial Therapeutics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Antimicrobial Therapeutics Revenue in 2019
3.3 Antimicrobial Therapeutics Key Players Head office and Area Served
3.4 Key Players Antimicrobial Therapeutics Product Solution and Service
3.5 Date of Enter into Antimicrobial Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Antimicrobial Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Antimicrobial Therapeutics Forecasted Market Size by Type (2021-2026)

5 ANTIMICROBIAL THERAPEUTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Antimicrobial Therapeutics Market Size by Application (2015-2020)
5.2 Global Antimicrobial Therapeutics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Antimicrobial Therapeutics Market Size (2015-2020)
6.2 Antimicrobial Therapeutics Key Players in North America (2019-2020)
6.3 North America Antimicrobial Therapeutics Market Size by Type (2015-2020)
6.4 North America Antimicrobial Therapeutics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Antimicrobial Therapeutics Market Size (2015-2020)
7.2 Antimicrobial Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Antimicrobial Therapeutics Market Size by Type (2015-2020)
7.4 Europe Antimicrobial Therapeutics Market Size by Application (2015-2020)

8 CHINA

8.1 China Antimicrobial Therapeutics Market Size (2015-2020)
8.2 Antimicrobial Therapeutics Key Players in China (2019-2020)
8.3 China Antimicrobial Therapeutics Market Size by Type (2015-2020)
8.4 China Antimicrobial Therapeutics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Antimicrobial Therapeutics Market Size (2015-2020)
9.2 Antimicrobial Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Antimicrobial Therapeutics Market Size by Type (2015-2020)
9.4 Japan Antimicrobial Therapeutics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Antimicrobial Therapeutics Market Size (2015-2020)
10.2 Antimicrobial Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Antimicrobial Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Antimicrobial Therapeutics Market Size by Application (2015-2020)

11 INDIA

11.1 India Antimicrobial Therapeutics Market Size (2015-2020)
11.2 Antimicrobial Therapeutics Key Players in India (2019-2020)
11.3 India Antimicrobial Therapeutics Market Size by Type (2015-2020)
11.4 India Antimicrobial Therapeutics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Antimicrobial Therapeutics Market Size (2015-2020)
12.2 Antimicrobial Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Antimicrobial Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Antimicrobial Therapeutics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Gilead Sciences, Inc.
  13.1.1 Gilead Sciences, Inc. Company Details
  13.1.2 Gilead Sciences, Inc. Business Overview and Its Total Revenue
  13.1.3 Gilead Sciences, Inc. Antimicrobial Therapeutics Introduction
  13.1.4 Gilead Sciences, Inc. Revenue in Antimicrobial Therapeutics Business (2015-2020))
  13.1.5 Gilead Sciences, Inc. Recent Development
13.2 GlaxoSmithKline plc
  13.2.1 GlaxoSmithKline plc Company Details
  13.2.2 GlaxoSmithKline plc Business Overview and Its Total Revenue
  13.2.3 GlaxoSmithKline plc Antimicrobial Therapeutics Introduction
  13.2.4 GlaxoSmithKline plc Revenue in Antimicrobial Therapeutics Business (2015-2020)
  13.2.5 GlaxoSmithKline plc Recent Development
13.3 Merck & Co Inc.
  13.3.1 Merck & Co Inc. Company Details
  13.3.2 Merck & Co Inc. Business Overview and Its Total Revenue
  13.3.3 Merck & Co Inc. Antimicrobial Therapeutics Introduction
  13.3.4 Merck & Co Inc. Revenue in Antimicrobial Therapeutics Business (2015-2020)
  13.3.5 Merck & Co Inc. Recent Development
13.4 Pfizer Inc.
  13.4.1 Pfizer Inc. Company Details
  13.4.2 Pfizer Inc. Business Overview and Its Total Revenue
  13.4.3 Pfizer Inc. Antimicrobial Therapeutics Introduction
  13.4.4 Pfizer Inc. Revenue in Antimicrobial Therapeutics Business (2015-2020)
  13.4.5 Pfizer Inc. Recent Development
13.5 Sanofi
  13.5.1 Sanofi Company Details
  13.5.2 Sanofi Business Overview and Its Total Revenue
  13.5.3 Sanofi Antimicrobial Therapeutics Introduction
  13.5.4 Sanofi Revenue in Antimicrobial Therapeutics Business (2015-2020)
  13.5.5 Sanofi Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

LIST OF TABLES

Table 1. Antimicrobial Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Antimicrobial Therapeutics Revenue
Table 3. Ranking of Global Top Antimicrobial Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Antimicrobial Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Hospital
Table 6. Key Players of Clinic
Table 7. Key Players of Personal
Table 8. Key Players of Other
Table 9. COVID-19 Impact Global Market: (Four Antimicrobial Therapeutics Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Antimicrobial Therapeutics Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Antimicrobial Therapeutics Players to Combat Covid-19 Impact
Table 14. Global Antimicrobial Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Antimicrobial Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Antimicrobial Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Antimicrobial Therapeutics Market Share by Regions (2015-2020)
Table 18. Global Antimicrobial Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Antimicrobial Therapeutics Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Antimicrobial Therapeutics Market Growth Strategy
Table 24. Main Points Interviewed from Key Antimicrobial Therapeutics Players
Table 25. Global Antimicrobial Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 26. Global Antimicrobial Therapeutics Market Share by Players (2015-2020)
Table 27. Global Top Antimicrobial Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antimicrobial Therapeutics as of 2019)
Table 28. Global Antimicrobial Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Antimicrobial Therapeutics Product Solution and Service
Table 31. Date of Enter into Antimicrobial Therapeutics Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Antimicrobial Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 34. Global Antimicrobial Therapeutics Market Size Share by Type (2015-2020)
Table 35. Global Antimicrobial Therapeutics Revenue Market Share by Type (2021-2026)
Table 36. Global Antimicrobial Therapeutics Market Size Share by Application (2015-2020)
Table 37. Global Antimicrobial Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 38. Global Antimicrobial Therapeutics Market Size Share by Application (2021-2026)
Table 39. North America Key Players Antimicrobial Therapeutics Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Antimicrobial Therapeutics Market Share (2019-2020)
Table 41. North America Antimicrobial Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 42. North America Antimicrobial Therapeutics Market Share by Type (2015-2020)
Table 43. North America Antimicrobial Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 44. North America Antimicrobial Therapeutics Market Share by Application (2015-2020)
Table 45. Europe Key Players Antimicrobial Therapeutics Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Antimicrobial Therapeutics Market Share (2019-2020)
Table 47. Europe Antimicrobial Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Antimicrobial Therapeutics Market Share by Type (2015-2020)
Table 49. Europe Antimicrobial Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Antimicrobial Therapeutics Market Share by Application (2015-2020)
Table 51. China Key Players Antimicrobial Therapeutics Revenue (2019-2020) (Million US$)
Table 52. China Key Players Antimicrobial Therapeutics Market Share (2019-2020)
Table 53. China Antimicrobial Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 54. China Antimicrobial Therapeutics Market Share by Type (2015-2020)
Table 55. China Antimicrobial Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 56. China Antimicrobial Therapeutics Market Share by Application (2015-2020)
Table 57. Japan Key Players Antimicrobial Therapeutics Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Antimicrobial Therapeutics Market Share (2019-2020)
Table 59. Japan Antimicrobial Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Antimicrobial Therapeutics Market Share by Type (2015-2020)
Table 61. Japan Antimicrobial Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Antimicrobial Therapeutics Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Antimicrobial Therapeutics Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Antimicrobial Therapeutics Market Share (2019-2020)
Table 65. Southeast Asia Antimicrobial Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Antimicrobial Therapeutics Market Share by Type (2015-2020)
Table 67. Southeast Asia Antimicrobial Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Antimicrobial Therapeutics Market Share by Application (2015-2020)
Table 69. India Key Players Antimicrobial Therapeutics Revenue (2019-2020) (Million US$)
Table 70. India Key Players Antimicrobial Therapeutics Market Share (2019-2020)
Table 71. India Antimicrobial Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 72. India Antimicrobial Therapeutics Market Share by Type (2015-2020)
Table 73. India Antimicrobial Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 74. India Antimicrobial Therapeutics Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Antimicrobial Therapeutics Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Antimicrobial Therapeutics Market Share (2019-2020)
Table 77. Central & South America Antimicrobial Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Antimicrobial Therapeutics Market Share by Type (2015-2020)
Table 79. Central & South America Antimicrobial Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Antimicrobial Therapeutics Market Share by Application (2015-2020)
Table 81. Gilead Sciences, Inc. Company Details
Table 82. Gilead Sciences, Inc. Business Overview
Table 83. Gilead Sciences, Inc. Product
Table 84. Gilead Sciences, Inc. Revenue in Antimicrobial Therapeutics Business (2015-2020) (Million US$)
Table 85. Gilead Sciences, Inc. Recent Development
Table 86. GlaxoSmithKline plc Company Details
Table 87. GlaxoSmithKline plc Business Overview
Table 88. GlaxoSmithKline plc Product
Table 89. GlaxoSmithKline plc Revenue in Antimicrobial Therapeutics Business (2015-2020) (Million US$)
Table 90. GlaxoSmithKline plc Recent Development
Table 91. Merck & Co Inc. Company Details
Table 92. Merck & Co Inc. Business Overview
Table 93. Merck & Co Inc. Product
Table 94. Merck & Co Inc. Revenue in Antimicrobial Therapeutics Business (2015-2020) (Million US$)
Table 95. Merck & Co Inc. Recent Development
Table 96. Pfizer Inc. Company Details
Table 97. Pfizer Inc. Business Overview
Table 98. Pfizer Inc. Product
Table 99. Pfizer Inc. Revenue in Antimicrobial Therapeutics Business (2015-2020) (Million US$)
Table 100. Pfizer Inc. Recent Development
Table 101. Sanofi Company Details
Table 102. Sanofi Business Overview
Table 103. Sanofi Product
Table 104. Sanofi Revenue in Antimicrobial Therapeutics Business (2015-2020) (Million US$)
Table 105. Sanofi Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Antimicrobial Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Hospital Features
Figure 3. Clinic Features
Figure 4. Personal Features
Figure 5. Other Features
Figure 6. Global Antimicrobial Therapeutics Market Share by Application: 2020 VS 2026
Figure 7. Antiviral Case Studies
Figure 8. Antibacterial Case Studies
Figure 9. Antifungal Case Studies
Figure 10. Antiparasitic Case Studies
Figure 11. Antimicrobial Therapeutics Report Years Considered
Figure 12. Global Antimicrobial Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Antimicrobial Therapeutics Market Share by Regions: 2020 VS 2026
Figure 14. Global Antimicrobial Therapeutics Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Antimicrobial Therapeutics Market Share by Players in 2019
Figure 17. Global Top Antimicrobial Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antimicrobial Therapeutics as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Antimicrobial Therapeutics Revenue in 2019
Figure 19. North America Antimicrobial Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Antimicrobial Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Antimicrobial Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Antimicrobial Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Antimicrobial Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Antimicrobial Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Antimicrobial Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Gilead Sciences, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Gilead Sciences, Inc. Revenue Growth Rate in Antimicrobial Therapeutics Business (2015-2020)
Figure 28. GlaxoSmithKline plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. GlaxoSmithKline plc Revenue Growth Rate in Antimicrobial Therapeutics Business (2015-2020)
Figure 30. Merck & Co Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Merck & Co Inc. Revenue Growth Rate in Antimicrobial Therapeutics Business (2015-2020)
Figure 32. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Pfizer Inc. Revenue Growth Rate in Antimicrobial Therapeutics Business (2015-2020)
Figure 34. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Sanofi Revenue Growth Rate in Antimicrobial Therapeutics Business (2015-2020)
Figure 36. Bottom-up and Top-down Approaches for This Report
Figure 37. Data Triangulation
Figure 38. Key Executives Interviewed


More Publications